BetaEntity Annotation Prototype

Entity family

Browse clinical instruments

Named questionnaires, scales, scores, indices, and other clinical outcome assessments. Examples include PHQ-9, GAD-7, EQ-5D.

36articles mentioning clinical instruments
52clinical instrument mentions
1distinct clinical instruments extracted
0%of mentions human-reviewed
Active filtersEntity: ECOG Performance Status ×

ECOG Performance Status

This clinical instrument is selected. Its supporting articles are shown below.

Articles mentioning ECOG Performance Status

36 articles · page 2 of 3
ECOG Performance Statusunresectable hepatocellular carcinomasorafeniblenvatinibnivolumabipilimumabNIVOSORunresectable HCCIPI

… untreated lesion per RECIST v1.1, Child–Pugh score 5 or 6, and ECOG performance status 0 or 1 were included. Pts were randomized 1:1 to receive NIVO 1…

ECOG Performance StatusdocetaxelrezvilutamideomHSPColigometastatic hormone-sensitive prostate cancer (omHSPC)First Affiliated Hospital of Wenzhou Medical UniversityADTandrogen deprivation therapyneoadjuvant therapy

…aire, time to symptomatic progression, time to deterioration in Eastern Cooperative Oncology Group performance status, the interval from enrolment to an increase in score from basel…

ECOG Performance StatusTisagenlecleucelKymriahhematologic malignanciesTecartusbrexucabtagén autoleucelYescartaAxicabtagén ciloleucelmantle cell lymphomadiffuse large B-cell lymphoma+5 more

…ry mediastinal large B-cell lymphoma (LBMP) in 2.9% of patients.ECOG performance status was 0 in 80.8%, 1 in 15.4%, and 2 in 3.8% of patients.Patients …

ECOG Performance Statusgastric or gastro-oesophageal junction adenocarcinomacamrelizumaboxaliplatinapatinibcapecitabinecamreCAPOX

…pa, CAPOX only, or camre+CAPOX followed by camre, stratified by Eastern Cooperative Oncology Group performance status, peritoneal metastasis, and programmed death ligand 1 (PD-L1) c…

ECOG Performance StatuspMMR CRCEastern Cooperative Oncology Groupnivolumab

… advanced/metastatic pMMR CRC with >1% MHC class II expression, Eastern Cooperative Oncology Group performance status 0–2, aged ≥18 years were eligible. Participants received 480 mg…

ECOG Performance StatusencorafenibmelanomavemurafenibbinimetinibcobimetinibdabrafenibNIVO+RELAatezolizumabEastern Cooperative Oncology Group+1 more

…EM+COBI; for purposes of the analyses, the missing category and ECOG performance status of 1 were pooled, resulting in a conservative approach for the …

ECOG Performance StatusHCB101non-Hodgkin lymphomaTAIPEI VETERANS GENERAL HOSPITAL Institutional Review BoardNational Taiwan University HospitalEastern Cooperative Oncology GroupHangzhou First People’s Hospital Ethics Committee

… tumors or non-Hodgkin lymphoma (NHL). Eligible patients had an Eastern Cooperative Oncology Group performance status of 0-2 and adequate organ function. Using a Bayesian Optimal In…

ECOG Performance StatusDana-Farber Cancer InstitutePHASE ONE FoundationIL-12myeloid leukemiaIL-15IL-18PROCpembrolizumabDana-Farber/Harvard Cancer Center+6 more

…confined to the abdominopelvic cavity, adequate organ function, ECOG performance status ≤1, and suitable for peritoneal catheter insertion. Patients un…